The "2026 Glaucoma Surgical Device Market Report" provides expanded coverage on several fronts, reflecting the rapid evolution of glaucoma surgery. New analysis includes a dedicated suprachoroidal device category, recognizing the growing role of this aqueous drainage pathway, along with updated product classifications based on the drainage site to better align with how surgeons evaluate treatment options in practice. The report also adds extensive forecast insights across all eight regional markets, enhanced reimbursement and regulatory analysis covering product approval pathways by region, and a dedicated section tracking the progress of sustained drug-delivery technologies.
Coverage of emerging technologies has also been significantly updated, with new analysis and forecasts for next-generation glaucoma laser platforms entering the market, including Alcon's DSLT, ViaLase's ViaLuxe, and Bausch + Lomb's Elios. Together with updated competitive analysis and market forecasts through 2031, these additions provide a more complete view of the technologies, market dynamics, and regulatory factors shaping the future of glaucoma surgical care.
The “2026 Glaucoma Surgical Device Market Report” provides a comprehensive analysis of the global glaucoma surgical device market, examining the technologies, clinical trends, competitive landscape, and market forces shaping the future of glaucoma surgery across every major region.
The report explores global glaucoma prevalence, treatment patterns, and the continued evolution of surgical care. It provides in-depth coverage of commercially available devices—including trabecular meshwork (TM) bypass stents, subconjunctival shunts, canal surgery devices, suprachoroidal devices, and tube shunts—while also assessing emerging technologies and investigational products expected to influence future treatment strategies and market growth.
Detailed market forecasts through 2031 provide unit and revenue projections across major device categories, procedure types, and geographic markets. The report also features competitive market share analysis, adoption trends, and comprehensive profiles of leading manufacturers and emerging innovators, providing a clear view of the companies and technologies driving the next phase of the glaucoma surgical device market.
The “2026 Glaucoma Surgical Device Market Report” provides a comprehensive and strategic analysis of the global glaucoma surgical device market, covering current technologies, emerging innovations, and the competitive landscape across the major device categories, including trabecular meshwork (TM) bypass stents, subconjunctival shunts, canal surgery devices, suprachoroidal devices, tube shunts, and glaucoma lasers. The report features detailed five-year forecasts, unit and revenue estimates, and competitive market share analysis across every major region.
The report also features:
Backed by Market Scope's proprietary market models, primary research, and decades of ophthalmic industry expertise, this report provides manufacturers, investors, and industry leaders with the data and strategic insights needed to evaluate market opportunities, benchmark competitors, and plan for the future of the global glaucoma surgical device market.
2 licensing types are available for this report:
Both licenses include an electronic PDF. Printed copies may be purchased for an additional $250.
SINGLE USER LICENSE
ENTERPRISE LICENSE
Pay by credit card or by invoice.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.